Fresh from winning a Grammy Award, and following a widely praised performance at the award show, Justin Bieber will launch his Purpose World Tour. The "Sorry" singer announced the tour back in November during a guest appearance on The Ellen DeGeneres Show, and anticipation has been building since.
The Purpose tour kicks off March 9 in Seattle and will weave through North America until July 18, where it wraps up at New York City's Madison Square Garden. The second leg of the tour will launch in Europe on Aug. 20. Due to overwhelming demand, Bieber added shows in Los Angeles, Atlanta, Philadelphia, Boston, Miami and New York, among others. The Purpose Tour will hit a total of 64 cities, and tickets will not be cheap for last-minute buyers. The tour represents a comeback of sorts for Bieber who has had seemingly as many downs as ups in recent years.
When tickets went on sale towards the end of 2015, they averaged $276 with the highest demand in the U.S. at his March 20 stop in Los Angeles at The Staples Center. Tickets in Los Angeles averaged $352 with a get-in of $92.
Since then, ticket prices have risen dramatically. With just a week before the tour begins, resale tickets are averaging $444 with huge demand in cities like Newark, N.J., Houston, Las Vegas, Brooklyn, and Boston. Bieber will play his most expensive show on July 9 in Newark at the Prudential Center, where tickets are averaging an impressive $759 with the cheapest ticket priced at $180.
His cheapest date is in Baltimore. Tickets for his July 7 stop at the Royal Farms Arena are averaging $244 with the cheapest ticket priced at just over $100, according to data provided by TiqIQ.
Justin Bieber tickets are expensive for good reason. The soon-to-be 22-year-old singer has been dominating the charts for months with huge singles like
The Stratford, Ontario native took home his first-ever Grammy on Feb. 15 for Best Dance Recording for the song "Where Are U Now" alongside EDM hitmakers Diplo and Skrillex. The trio also performed the track onstage at the awards show to wide aclaim.
This article is commentary by an independent contributor. At the time of publication, the author held no positions in the stocks mentioned.